Hims & Hers Health Inc. buy Guggenheim
Start price
28.02.23
/
50%
€11.00
Target price
28.02.24
€14.12
Performance (%)
12.73%
End price
29.02.24
€12.40
Summary
This prediction ended on 29.02.24 with a price of €12.40. The prediction had a final performance of 12.73%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hims & Hers Health Inc. | -2.510% | -2.510% | -58.454% | 195.098% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % | 53,61 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % | 72,78 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % | 62,43 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % | 60,74 % |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $15.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
In the thread Trading Hims & Hers Health Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€12.65
27.02.24
27.02.24
€15.66
27.02.25
27.02.25
208.38%
28.02.25
28.02.25
